Abstract
To evaluate the prevalence of intermediate-stage age-related macular degeneration (AMD) in patients with acquired immunodeficiency syndrome (AIDS). Cross-sectional study of patients with AIDS enrolled in the Longitudinal Study of the Ocular Complications of AIDS. Intermediate-stage AMD was determined from enrollment retinal photographs by graders at a centralized Reading Center, using the Age-Related Eye Disease Study grading system. Graders were masked as to clinical data. Of 1825 participants with AIDS and no ocular opportunistic infections, 9.9% had intermediate-stage AMD. Risk factors included age, with an odds ratio (OR) of 1.9 (95% confidence interval [CI] 1.6, 2.3, P < .001) for every decade of age; the prevalence of AMD ranged from 4.0% for participants 30-39 years old to 24.3% for participants ≥60 years old. Other risk factors included the human immunodeficiency virus (HIV) risk groups of injection drug use (OR = 2.4, 95% CI 1.5, 3.9, P < .001) or heterosexual contact (OR = 1.9, 95% CI 1.3, 2.8, P = .001). Compared with the HIV-uninfected population in the Beaver Dam Offspring Study, there was an approximate 4-fold increased age-adjusted prevalence of intermediate-stage AMD. Patients with AIDS have an increased age-adj...Continue Reading
References
Mar 27, 1998·The New England Journal of Medicine·F J PalellaS D Holmberg
Aug 8, 1998·The New England Journal of Medicine·S H MichaelsP Kissinger
Apr 14, 2004·Archives of Ophthalmology·David S FriedmanUNKNOWN Eye Diseases Prevalence Research Group
Nov 16, 2005·Archives of Ophthalmology·Frederick L FerrisUNKNOWN Age-Related Eye Disease Study (AREDS) Research Group
Mar 4, 2006·Ophthalmology·Ronald KleinDavid R Jacobs
Dec 26, 2006·Ophthalmology·Yinkang DuanDuanping Liao
Jan 11, 2007·Ophthalmology·Douglas A JabsUNKNOWN Studies of the Ocular Complications of AIDS Research Group
Jan 18, 2007·Annals of Internal Medicine·Nicolai LohseNiels Obel
Jan 30, 2007·Ophthalmology·Douglas A JabsUNKNOWN Studies of the Ocular Complications of AIDS Research Group
Feb 6, 2007·Ophthalmology·Jennifer S L TanJie Jin Wang
Sep 21, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert C KaplanStephen J Gange
Feb 7, 2008·Annals of Internal Medicine·R Scott BraithwaiteAmy C Justice
Jul 29, 2008·Lancet·UNKNOWN Antiretroviral Therapy Cohort Collaboration
Jul 14, 2009·Ophthalmology·Cong SunTien Y Wong
Nov 26, 2010·Annual Review of Medicine·Steven G Deeks
Feb 9, 2012·American Journal of Ophthalmology·Elizabeth A SugarUNKNOWN Studies of the Ocular Complications of AIDS Research Group
Feb 9, 2013·JAMA Ophthalmology·Vinod P MittaDebra A Schaumberg
Aug 28, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Megan L SalterGregory D Kirk
Oct 26, 2013·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Sophia PathaiKevin P High
Apr 1, 2014·PloS One·Juan WuDebra A Schaumberg
Apr 24, 2014·The Journal of Infectious Diseases·Peter W HuntMichael M Lederman
Jul 25, 2014·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Khaled NassarSwaantje Grisanti
Nov 22, 2014·Science·Benjamin J FowlerJayakrishna Ambati
Citations
May 20, 2017·Epidemiology and Infection·E SchaftenaarR P H Peters
Jul 12, 2017·HIV Medicine·A W JabsUNKNOWN Studies of the Ocular Complications of AIDS Research Group
Mar 18, 2020·Acta Ophthalmologica·Arvin NahavandipourYousif Subhi
Jul 16, 2020·Ophthalmic Epidemiology·Jian-Yu EXiangrong Kong
Nov 3, 2017·Frontiers in Immunology·Walter Fierz
May 21, 2019·Investigative Ophthalmology & Visual Science·Douglas A JabsPeter W Hunt
Feb 14, 2021·Archivos de la Sociedad Española de Oftalmología·S A Gómez-GualdrónP A Camacho-López
Oct 23, 2020·EClinicalMedicine·Charlotte LiisborgTorben Lykke Sørensen
Dec 16, 2018·American Journal of Ophthalmology·Douglas A JabsPeter W Hunt
May 14, 2017·American Journal of Ophthalmology·Douglas A JabsPeter W Hunt
May 1, 2021·Viruses·Chih-Ching YehFu-Hsiung Su
Jan 1, 2017·Ophthalmology Retina·Aniruddha AgarwalUNKNOWN OCTA Study Group